Lauren Riker Biography and Net Worth



Presently, Lauren Bullaro Riker holds the position of Vice President-Finance at Pacira Biosciences, Inc. Ms. Riker is also on the board of Pacira Ltd.

Ms. Riker received an undergraduate degree from Boston College and an MBA from Columbia University.

What is Lauren Bullaro Riker's net worth?

The estimated net worth of Lauren Bullaro Riker is at least $608,238.47 as of July 5th, 2023. Ms. Riker owns 22,687 shares of Pacira BioSciences stock worth more than $608,238 as of April 23rd. This net worth approximation does not reflect any other investments that Ms. Riker may own. Additionally, Ms. Riker receives a salary of $288,810.00 as VP at Pacira BioSciences. Learn More about Lauren Bullaro Riker's net worth.

How old is Lauren Bullaro Riker?

Ms. Riker is currently 45 years old. There are 7 older executives and no younger executives at Pacira BioSciences. The oldest executive at Pacira BioSciences is Mr. David M. Stack, Advisor, who is 74 years old. Learn More on Lauren Bullaro Riker's age.

What is Lauren Bullaro Riker's salary?

As the VP of Pacira BioSciences, Inc., Ms. Riker earns $288,810.00 per year. There are 6 executives that earn more than Ms. Riker. The highest earning executive at Pacira BioSciences is Mr. David M. Stack, Advisor, who commands a salary of $1,540,000.00 per year. Learn More on Lauren Bullaro Riker's salary.

How do I contact Lauren Bullaro Riker?

The corporate mailing address for Ms. Riker and other Pacira BioSciences executives is 5 SYLVAN WAY SUITE 300, PARSIPPANY NJ, 07054. Pacira BioSciences can also be reached via phone at (813) 553-6680 and via email at [email protected]. Learn More on Lauren Bullaro Riker's contact information.

Has Lauren Bullaro Riker been buying or selling shares of Pacira BioSciences?

Lauren Bullaro Riker has not been actively trading shares of Pacira BioSciences during the last ninety days. Most recently, Lauren Bullaro Riker sold 643 shares of the business's stock in a transaction on Wednesday, July 5th. The shares were sold at an average price of $38.91, for a transaction totalling $25,019.13. Following the completion of the sale, the senior vice president now directly owns 22,687 shares of the company's stock, valued at $882,751.17. Learn More on Lauren Bullaro Riker's trading history.

Who are Pacira BioSciences' active insiders?

Pacira BioSciences' insider roster includes Donald Manning (Insider), Max Reinhardt (Insider), Charles Reinhart, III (CFO), Lauren Riker (VP), David Stack (CEO), Andreas Wicki (Director), Kristen Williams (Insider), and Roy Winston (Insider). Learn More on Pacira BioSciences' active insiders.

Are insiders buying or selling shares of Pacira BioSciences?

In the last twelve months, insiders at the sold shares 16 times. They sold a total of 138,857 shares worth more than $4,613,719.15. The most recent insider tranaction occured on March, 8th when Director Gary W Pace sold 90,000 shares worth more than $2,754,000.00. Insiders at Pacira BioSciences own 6.6% of the company. Learn More about insider trades at Pacira BioSciences.

Information on this page was last updated on 3/8/2024.

Lauren Bullaro Riker Insider Trading History at Pacira BioSciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/5/2023Sell643$38.91$25,019.1322,687View SEC Filing Icon  
6/14/2023Sell6,366$38.42$244,581.7222,687View SEC Filing Icon  
6/6/2023Sell591$38.99$23,043.0919,669View SEC Filing Icon  
6/6/2022Sell1,150$61.37$70,575.5014,002View SEC Filing Icon  
3/10/2022Sell9,300$71.22$662,346.00View SEC Filing Icon  
1/18/2022Sell2,500$64.97$162,425.00View SEC Filing Icon  
7/29/2021Sell90$60.81$5,472.90View SEC Filing Icon  
6/11/2021Sell2,003$59.85$119,879.5514,734View SEC Filing Icon  
6/4/2021Sell1,047$61.04$63,908.8812,134View SEC Filing Icon  
3/17/2021Sell2,000$70.01$140,020.0014,701View SEC Filing Icon  
3/15/2021Sell1,520$73.28$111,385.6014,701View SEC Filing Icon  
9/16/2020Sell3,000$60.34$181,020.0016,181View SEC Filing Icon  
8/11/2020Sell8,180$60.50$494,890.0020,813View SEC Filing Icon  
6/29/2020Sell6,000$49.47$296,820.0018,633View SEC Filing Icon  
6/4/2020Sell879$46.33$40,724.079,585View SEC Filing Icon  
5/21/2020Sell2,000$45.26$90,520.0012,464View SEC Filing Icon  
5/19/2020Sell2,000$42.81$85,620.0012,464View SEC Filing Icon  
2/7/2020Sell170$46.81$7,957.7011,294View SEC Filing Icon  
11/20/2019Sell1,176$44.14$51,908.6411,640View SEC Filing Icon  
11/11/2019Sell5,000$43.59$217,950.00View SEC Filing Icon  
6/10/2019Sell2,126$44.28$94,139.2810,042View SEC Filing Icon  
6/4/2019Sell967$42.91$41,493.97View SEC Filing Icon  
11/2/2018Sell1,000$54.35$54,350.0011,474View SEC Filing Icon  
9/24/2018Sell1,000$50.70$50,700.0011,474View SEC Filing Icon  
8/22/2018Sell1,667$44.48$74,148.1610,474View SEC Filing Icon  
6/4/2018Sell801$33.02$26,449.029,641View SEC Filing Icon  
12/15/2017Sell340$43.70$14,858.00View SEC Filing Icon  
6/5/2017Sell601$43.32$26,035.32View SEC Filing Icon  
6/7/2016Sell938$47.66$44,705.085,945View SEC Filing Icon  
6/6/2016Sell321$47.20$15,151.205,945View SEC Filing Icon  
3/16/2015Sell5,000$95.34$476,700.00View SEC Filing Icon  
See Full Table

Lauren Bullaro Riker Buying and Selling Activity at Pacira BioSciences

This chart shows Lauren Bullaro Riker's buying and selling at Pacira BioSciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Pacira BioSciences Company Overview

Pacira BioSciences logo
Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature to targeted nerves. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
Read More

Today's Range

Now: $26.81
Low: $26.19
High: $27.08

50 Day Range

MA: $28.96
Low: $26.10
High: $31.41

2 Week Range

Now: $26.81
Low: $25.74
High: $48.60

Volume

497,168 shs

Average Volume

496,138 shs

Market Capitalization

$1.25 billion

P/E Ratio

33.10

Dividend Yield

N/A

Beta

0.76